Immunostimulation and Immunosuppression: Nanotechnology on the brink

Flavia Fontana, Patricia Isabel Figueiredo, Tomás Bauleth-Ramos, Alexandra Correia, Helder Almeida Santos

Research output: Contribution to journalReview ArticleScientificpeer-review

Abstract

Immunotherapy is revolutionizing current therapies in cancer and in autoimmune diseases, showing impressive results in clinical trials. Recently, the development of innovative nanobiomaterials is focusing on the interactions between such materials and the immune
system, both in the adaptive and innate branches. Biomaterials can display immunostimulative, neutral, or immunosuppressive interactions. Nanoparticles displaying immunostimulative potential are employed in the formulation of cancer vaccines, while
immunosuppressive materials are being researched for the development of vaccines able to induce tolerance in autoimmune diseases. Here, it is analyzed the properties influencing the immunomodulation effect of nanomaterials, followed by a detailed review of the recent
applications of nanomaterials for the delivery of antigens, adjuvants, chemotherapeutics, and immunomodulatory drugs.
Original languageEnglish
Article number1700347
JournalSmall methods
Volume2
Issue number5
Number of pages33
ISSN2366-9608
DOIs
Publication statusPublished - 11 May 2018
MoE publication typeA2 Review article in a scientific journal

Fields of Science

  • 317 Pharmacy
  • 221 Nano-technology
  • autoimmune diseases
  • cancer immunotherapy
  • drug-delivery systems
  • nanoparticles
  • vaccines

Cite this

@article{5a75ddb86a714fd3ad59f20d14a94efd,
title = "Immunostimulation and Immunosuppression: Nanotechnology on the brink",
abstract = "Immunotherapy is revolutionizing current therapies in cancer and in autoimmune diseases, showing impressive results in clinical trials. Recently, the development of innovative nanobiomaterials is focusing on the interactions between such materials and the immune system, both in the adaptive and innate branches. Biomaterials can display immunostimulative, neutral, or immunosuppressive interactions. Nanoparticles displaying immunostimulative potential are employed in the formulation of cancer vaccines, while immunosuppressive materials are being researched for the development of vaccines able to induce tolerance in autoimmune diseases. Here, it is analyzed the properties influencing the immunomodulation effect of nanomaterials, followed by a detailed review of the recent applications of nanomaterials for the delivery of antigens, adjuvants, chemotherapeutics, and immunomodulatory drugs.",
keywords = "317 Pharmacy, 221 Nano-technology, autoimmune diseases, cancer immunotherapy, drug-delivery systems, nanoparticles, vaccines",
author = "Flavia Fontana and Figueiredo, {Patricia Isabel} and Tom{\'a}s Bauleth-Ramos and Alexandra Correia and {Almeida Santos}, Helder",
year = "2018",
month = "5",
day = "11",
doi = "10.1002/smtd.201700347",
language = "English",
volume = "2",
journal = "Small methods",
issn = "2366-9608",
publisher = "John Wiley & Sons Ltd.",
number = "5",

}

Immunostimulation and Immunosuppression: Nanotechnology on the brink. / Fontana, Flavia; Figueiredo, Patricia Isabel; Bauleth-Ramos, Tomás; Correia, Alexandra; Almeida Santos, Helder.

In: Small methods, Vol. 2, No. 5, 1700347, 11.05.2018.

Research output: Contribution to journalReview ArticleScientificpeer-review

TY - JOUR

T1 - Immunostimulation and Immunosuppression: Nanotechnology on the brink

AU - Fontana, Flavia

AU - Figueiredo, Patricia Isabel

AU - Bauleth-Ramos, Tomás

AU - Correia, Alexandra

AU - Almeida Santos, Helder

PY - 2018/5/11

Y1 - 2018/5/11

N2 - Immunotherapy is revolutionizing current therapies in cancer and in autoimmune diseases, showing impressive results in clinical trials. Recently, the development of innovative nanobiomaterials is focusing on the interactions between such materials and the immune system, both in the adaptive and innate branches. Biomaterials can display immunostimulative, neutral, or immunosuppressive interactions. Nanoparticles displaying immunostimulative potential are employed in the formulation of cancer vaccines, while immunosuppressive materials are being researched for the development of vaccines able to induce tolerance in autoimmune diseases. Here, it is analyzed the properties influencing the immunomodulation effect of nanomaterials, followed by a detailed review of the recent applications of nanomaterials for the delivery of antigens, adjuvants, chemotherapeutics, and immunomodulatory drugs.

AB - Immunotherapy is revolutionizing current therapies in cancer and in autoimmune diseases, showing impressive results in clinical trials. Recently, the development of innovative nanobiomaterials is focusing on the interactions between such materials and the immune system, both in the adaptive and innate branches. Biomaterials can display immunostimulative, neutral, or immunosuppressive interactions. Nanoparticles displaying immunostimulative potential are employed in the formulation of cancer vaccines, while immunosuppressive materials are being researched for the development of vaccines able to induce tolerance in autoimmune diseases. Here, it is analyzed the properties influencing the immunomodulation effect of nanomaterials, followed by a detailed review of the recent applications of nanomaterials for the delivery of antigens, adjuvants, chemotherapeutics, and immunomodulatory drugs.

KW - 317 Pharmacy

KW - 221 Nano-technology

KW - autoimmune diseases

KW - cancer immunotherapy

KW - drug-delivery systems

KW - nanoparticles

KW - vaccines

UR - http://onlinelibrary.wiley.com/journal/10.1002/(ISSN)2366-9608

U2 - 10.1002/smtd.201700347

DO - 10.1002/smtd.201700347

M3 - Review Article

VL - 2

JO - Small methods

JF - Small methods

SN - 2366-9608

IS - 5

M1 - 1700347

ER -